• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Axonics Modulation downgraded by Needham

    10/10/22 7:11:07 AM ET
    $AXNX
    Medical/Dental Instruments
    Health Care
    Get the next $AXNX alert in real time by email
    Needham downgraded Axonics Modulation from Buy to Hold
    Get the next $AXNX alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $AXNX

    DatePrice TargetRatingAnalyst
    1/9/2024Outperform → Peer Perform
    Wolfe Research
    7/19/2023$69.00Outperform
    Robert W. Baird
    7/13/2023$70.00Overweight
    KeyBanc Capital Markets
    5/23/2023$75.00Buy
    CL King
    4/14/2023$75.00Buy
    Mizuho
    3/24/2023$71.00Hold → Buy
    Needham
    10/21/2022$85.00Outperform
    RBC Capital Mkts
    10/12/2022$75.00Hold
    Jefferies
    More analyst ratings